Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes

V. Cojocariu, A. Sorete-Arbore (Iasi, Romania)

Source: Annual Congress 2004 - Problems of resistances in tuberculosis
Session: Problems of resistances in tuberculosis
Session type: Thematic Poster Session
Number: 3991
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Cojocariu, A. Sorete-Arbore (Iasi, Romania). Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes. Eur Respir J 2004; 24: Suppl. 48, 3991

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Development of mycobacterium tuberculosis additional drug resistance during chemotherapy of disseminated pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 663s
Year: 2007

Pulmonary tuberculosis relapse or atypical mycobacterium infection?
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012

Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011

Primary drug resistance in pulmonary tuberculosis
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Exposure to mycobacterium tuberculosis during bronchoscopy in patients with unexpected pulmonary tuberculosis
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009



Treatment results of multidrug-resistant pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 11s
Year: 2006

Extrapulmonary tuberculosis
Source: Respipedia Article
Year: 2015

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
Source: Eur Respir J 2013; 41: 1393-1400
Year: 2013



Primary drug resistance rates in pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 42s
Year: 2003

Evaluation of treatment outcomes for multidrug-resistant tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001

Outcome of pulmonary multidrug-resistant tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 419s
Year: 2007

Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002

Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010



Pneumonectomy in lung infections with Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001

Multi-drug-resistant tuberculosis
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

Multi-drug-resistant tuberculosis
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012